Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ELIMIT Trial
NCT00687076Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Apr 2004
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, niacin in Peripheral Arterial Disease (PAD), sponsored by Baylor College of Medicine. Started Apr 2004; status: completed.
02
Drugs
ezetimibeniacin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00687076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687076.